Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "OctM pathway control state"

From Bioblast
(Created page with "{{MitoPedia |abbr=OctPGM |description='''OctPGM''': Octanoylcarnitine & Malate. '''MitoPathway control state:''' F '''SUIT protocols:''' 1OctM;2D;2c;3P;4S;5U;6Rot;...")
Β 
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=OctPGM
|abbr=OctM
|description='''OctPGM''': [[Octanoylcarnitine]] & [[Malate]].
|description='''OctM''': [[Octanoylcarnitine]] & [[Malate]].


'''MitoPathway control state:''' F
'''MitoPathway control state:''' F


'''SUIT protocols:''' [[1OctM;2D;2c;3P;4S;5U;6Rot;7Ama-]] - SUIT RP1, [[1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-]] - SUIT RP2
'''SUIT protocols:''' [[SUIT-002]] - SUIT RP2, [[SUIT-015]]
|info=[[MiPNet21.06 SUIT reference protocol]], [[SUIT reference protocol]]
|info=[[MiPNet21.06 SUIT reference protocol]], [[SUIT reference protocol]]
}}
}}
Line 12: Line 12:
}}
}}
== OctM(L) ==
== OctM(L) ==
Β 
:::#


== OctM(P) ==
== OctM(P) ==
:::# [[SUIT_FNSGp(PGM)02]]_'''5G''': 1D 2Oct 3Mtit&Mc (&McNADH) 4P '''<u>5G</u>''' 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd'''
:::# [[SUIT-002]]


== OctM(E) ==
== OctM(E) ==
:::# [[1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-]]_'''5G''': 1PM 2D&Dc (&DcNADH) 3U 4Oct '''<u>5G</u> 6S''' 7Rot 8Gp 9Ama 10Tm 11Azd
:::#
Β 
Β 
----
Β 
[[File:SUIT-Reference-Protocol 1.jpg|700px |1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-]]<br />
Β 
Β 
Β 
----
Β 
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]<br />


----
----

Revision as of 12:51, 15 January 2019


high-resolution terminology - matching measurements at high-resolution


OctM pathway control state

Description

OctM: Octanoylcarnitine & Malate.

MitoPathway control state: F

SUIT protocols: SUIT-002 - SUIT RP2, SUIT-015

Abbreviation: OctM

Reference: MiPNet21.06 SUIT reference protocol, SUIT reference protocol


MitoPedia concepts: SUIT state 

OctM(L)

OctM(P)

  1. SUIT-002

OctM(E)